Intradermal 5-HT induces Fos expression in rat dorsal horn neurons not via 5-HT3 but via 5-HT(2A) receptors

Neuroscience Research

Volumn 29, Issue 2, 1997, Pages 143-149

  Doi Saika, Misako ^a   Tokunaga, Atsushi ^a,b   Senba, Emiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

5 HT; 5 HT(2A) receptor agonist; Antagonist; C fiber; Dorsal horn; Fos protein; Nociception

Indexed keywords

2 METHYLSEROTONIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA METHYLSEROTONIN; KETANSERIN; SEROTONIN; SEROTONIN 2 AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 3 AGONIST; SEROTONIN 3 RECEPTOR; TROPISETRON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; IMMUNOREACTIVITY; MALE; NOCICEPTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN; SPINAL NERVE;

EID: 0030882127     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(97)00086-2     Document Type: Article

References (48)

1. 2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology 35, 99-110.
2. 1B receptor subtypes in modulating spinal nociceptive transmission in mice. J. Pharmacol. Exp. Ther. 265, 378-385.
3. Armstrong, D., Dry, R.M.L., Keele, C.A., Markham, J.W., 1953. Observations on chemical excitants of cutaneous pain in man. J. Physiol. 120, 326-351.
4. Beck, P.W., Handwerker, H.O., 1974. Bradykinin and serotonin effects on various types of cutaneous nerve fibres. Plügers Arch. 347, 209-222.
5. 1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat. J. Pharmacol. Exp. Ther. 264, 95-104.
6. Citra, A., Molander, C., Fuxe, K., 1993. Colocalization of Fos- and glucocorticoid receptor-immunoreactivities is present only in a very restricted population of dorsal horn neurons of the rat spinal cord after nociceptive stimulation. Brain Res. 632, 334-338.
7. De Clerck, F., Van Nueten, J.M., Reneman, R.S., 1984. Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review. Agents Actions 15, 612-626.
8. 2-receptor antagonist. Agents Actions 12, 388-397.
9. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238, 248-253.
10. Draisci, G., Indarola, M.J., 1989. Temporal analysis of increase in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6, 31-37.
11. 3 receptor antagonists reduce c-fos expression in the trigeminal nuclear complex following noxious chemical stimulation of the rat nasal mucosa. Brain Res. 676, 336-342.
12. Gaddum, J.H., Picarelli, Z.P., 1957. Two kinds of tryptamine receptor. Br. J. Pharmacol. 12, 323-328.
13. 3 receptor antagonists in the mouse. Neuropharmacology 28, 423-427.
14. 3 receptor antagonists reduce inflammatory pain in the rats. Eur. J. Pharmacol. 170, 83-86.
15. Graziano, F.M., 1988. Mast cells and mast cell products. Methods Enzymol. 162, 501-522.
16. Grubb, B.D., McQueen, D.S., Iggo, A., Birrell, G.J., Dutia, M.B., 1988. A study of 5-HT-receptors associated with afferent nerves located in normal and inflamed rat ankle joints. Agents Actions 25, 216-218.
17. Gupta, R.M., Bhide, M.B., 1979. Role of 5-HT in acute inflammation and anaphylaxis. Indian J. Med. Res. 69, 651-658.
18. Handwerker, H.O., 1979. Influences of algogenic substances and prostaglandins on discharges of unmyelinated cutaneous nerve fibers identified as nociceptors. Adv. Pain Res. Ther. 1, 41-45.
19. Herbert, M.K., Schmidt, R.F., 1992. Activation of normal and inflamed fine articular afferent units by serotonin. Pain 50, 79-88.
20. Hindle, A.T., 1994. Recent developments in the physiology and pharmacology of 5-hydroxytryptamine. Br. J. Anaesth. 73, 395-407.
21. Holsapple, M.P., Schnur, M., Yim, G.K.W., 1980. Pharmacological modulation of edema mediated by prostaglandin, serotonin and histamine. Agents Actions 10, 368-373.
22. Horigome, K., Pryor, J.C., Bullock, E.D., Johnson, E.M. Jr., 1993. Mediator release from mast cells by nerve growth factor. J. Biol. Chem. 268, 14881-14887.
23. Hoyer, D., Schoeffter, P., 1991. 5-HT receptors: subtypes and second messengers. J. Recept. Res. 11, 197-214.
24. Hoyer, D., Clerke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., Humphery, P.P., 1994. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
25. Hunt, S.P., Pini, A., Evan, G., 1989. Induction of c-fos-like protein spinal cord neurons following sensory stimulation. Nature 328, 632-634.
26. Lewin, G.R., Rueff, A.M., Mendell, L.M., 1994. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 6, 1903-1912.
27. Lindahl, O., 1961. Experimental skin pain induced by injection of water-soluble substances in humans. Acta Physiol. Scand. 51, 1-90.
28. Orwin, J.M., Fozard, J.R., 1986. Blockade of the fare response to intradermal 5-hydroxytryptamine in man by MDL 72.222, a selective antagonist at neuronal 5-hydroxytryptamine receptors. Eur. J. Clin. Pharmacol. 30, 209-212.
29. Peroutka, S.J., 1994. Molecular biology of serotonin (5-HT) receptors. Synapse 18, 241-260.
30. Peroutka, S.J., 1995. 5-HT receptors: past, present and future. Trends Neurosci. 18, 68-69.
31. Pierce, P.A., Xie, G.X., Levine, J.D., Peroutka, S.J., 1996. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70, 553-559.
32. Presley, R.W., Menétrey, D., Levine, J.D., Basbaum, A.I., 1990. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J. Neurosci. 10, 323-335.
33. Richardson, B.P., Engel, G., Donatsch, P., Stadler, P.A., 1985. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316, 126-131.
34. Rueff, A., Dray, A., 1992. 5-hydroxytryptamine-induced sensitization and activation of peripheral fibres in the neonatal rat are mediated via different 5-hydroxytryptamine-receptors. Neuroscience 50, 899-905.
35. Rueff, A., Dray, A., 1993. Pharmacological characterization of the effects of 5-hydroxytryptamine and different prostaglandins on peripheral sensory neurons in vitro. Agents Actions 38, C13-C15.
36. Sawynok, J., Reid, A., 1992. Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine: characterization of receptor subtypes. Eur. J. Pharmacol. 223, 49-56.
37. 1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95, 975-985.
38. Sufka, K.J., Schomburg, F.M., Giordano, J., 1991. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol. Biochem. Behav. 41, 53-56.
39. Sulowska, Z., Brzezinska-Blaszczyk, E., Czuwaj, M., 1987. Histamine- and serotonin-releasing activity of the supernatants from guinea pig spleen cell cultures. Arch. Immunol. Ther. Exp. 35, 541-546.
40. Taiwo, Y.O., Heller, P.H., Leviene, J.D., 1992. Mediation of serotonin hyperalgesia by the cAMP second messenger system. Neuroscience 48, 479-483.
41. Taiwo, Y.O., Levine, J.D., 1992. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 48, 485-490.
42. Taveres, I., Lima, D., Combra, A., 1993. Neurons in the superficial dorsal horn of the rat spinal cord projecting to the medullary ventrolateral reticular formation express c-fos after noxious stimulation of the skin. Brain Res. 623, 278-286.
43. 3 receptor mRNA. Proc. Natl. Acad. Sci. USA 90, 1430-1434.
44. 1A receptor. Brain Res. 585, 212-218.
45. Tölle, T.R., Castro-Lopes, J.M., Combra, A., Zieglglänsberger, W., 1990. Opiates modify of c-fos proto-oncogene in the spinal cord of the rat following noxious stimulation. Neurosci. Lett. 111, 46-51.
46. Van Wijngaarden, I., Tulp, M.T.M., Soudijn, W., 1990. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188, 301-312.
47. 1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J. Pharmacol. 120, 227-230.
48. Yao, G.L., Tohyama, M., Senba, E., 1992. Histamine-caused itch induces Fos-like immunoreactivity in dorsal horn neurons: effect of morphine pretreatment. Brain Res. 599, 333-337.